Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 115,694 | 164,186 | 228,752 | 134,188 | 114,888 |
| Marketable Securities | 208,087 | 233,302 | 183,864 | 222,007 | 164,979 |
| Receivables | 69,340 | 55,768 | 31,604 | 234 | 151 |
| Inventories | 51,520 | 38,578 | 27,854 | 17,617 | 10,372 |
| TOTAL | $457,018 | $498,578 | $482,257 | $385,533 | $307,848 |
| Non-Current Assets | |||||
| PPE Net | 109,081 | 112,520 | 110,960 | 111,789 | 114,030 |
| Intangibles | 282,398 | 306,639 | 295,299 | 294,303 | 229,258 |
| Other Non-Current Assets | 61,929 | 73,378 | 75,806 | 78,205 | 129,215 |
| TOTAL | $453,408 | $492,537 | $482,065 | $484,297 | $472,503 |
| Total Assets | $910,426 | $991,115 | $964,322 | $869,830 | $780,351 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 27,509 | 31,686 | 20,416 | 25,700 | 33,123 |
| Accrued Expenses | 81,936 | 74,819 | 61,787 | 46,436 | 69,406 |
| TOTAL | $122,341 | $118,056 | $93,639 | $83,214 | $110,306 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 |
| Other Non-Current Liabilities | 44,365 | 66,389 | 69,246 | 72,291 | 67,085 |
| TOTAL | $77,680 | $99,604 | $102,143 | $106,592 | $85,432 |
| Total Liabilities | $200,021 | $217,660 | $195,782 | $189,806 | $195,738 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 327,877 | 304,781 | 303,514 | 279,833 | 279,307 |
| Common Shares | 13 | 13 | 12 | 12 | 11 |
| Retained earnings | -2,384,552 | -2,305,993 | -2,222,452 | -2,125,351 | -2,012,375 |
| Other shareholders' equity | -1,046 | 16,242 | 526 | 116 | 2,526 |
| TOTAL | $710,405 | $773,455 | $768,540 | $680,024 | $584,613 |
| Total Liabilities And Equity | $910,426 | $991,115 | $964,322 | $869,830 | $780,351 |